Litcius/Paper detail

Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance

Min Xia, Xuyu Zu, Zuyao Chen, Gebo Wen, Jing Zhong

2021Cancer Letters36 citationsDOIOpen Access PDF

Abstract

Triple-negative breast cancer (TNBC) is the most aggressive subtype among breast cancers with high recurrence and this condition is partly due to chemoresistance. Therefore, fully understanding the mechanism of TNBC-resistance is the key to overcoming chemoresistance, which will be an effective strategy for TNBC therapy. Various potential mechanisms involved in the chemoresistance of TNBC have been investigated and indicated that noncoding RNAs (ncRNAs) especially microRNAs (miRNAs), long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) take part in most TNBC resistance. The ncRNA-induced chemoresistance process is involved in the alteration of many activities. here, we mainly summarize the mechanisms of ncRNAs in the chemoresistance of TNBC and discuss the potential clinical application of ncRNAs in the treatment of TNBC, indicating that targeting ncRNAs might be a promising strategy for resensitization to chemotherapies.

Topics & Concepts

Triple-negative breast cancermicroRNANon-coding RNABreast cancerBiologyMechanism (biology)Long non-coding RNACancer researchCancerComputational biologyBioinformaticsRNAGeneGeneticsEpistemologyPhilosophyCancer-related molecular mechanisms researchCircular RNAs in diseasesMicroRNA in disease regulation
Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance | Litcius